Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hypertension and Regulation of Blood Pressure

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...

Hypertension I: Introduction

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...

Obesity

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...

Drug Dosing: Obese Patients

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...

Hypertension II: Pathophysiology

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Myeloid transglutaminase 2 regulates Treg-Th17 balance in a female model of angiotensin II-induced hypertension and vascular stiffening.

American journal of physiology. Heart and circulatory physiology·2026

Same author

Vascular Smooth Muscle Cell TG2 Promotes DOCA/Salt-Induced Arterial Stiffness and Hypertension.

Hypertension (Dallas, Tex. : 1979)·2025

Same author

Prevention of cardiovascular disease in women with type 2 diabetes: the role of incretin mimetics and sodium-glucose cotransporter-2 inhibitors.

American journal of physiology. Cell physiology·2024

Same author

Enhanced ECCD36 signaling promotes skeletal muscle insulin resistance in female mice.

American journal of physiology. Endocrinology and metabolism·2024

Same author

The mineralocorticoid receptor in diabetic kidney disease.

American journal of physiology. Renal physiology·2024

Same author

Histological improvements following energy restriction and exercise: The role of insulin resistance in resolution of MASH.

Journal of hepatology·2024

Search research articles

Related Experiment Video

Updated: Jul 1, 2026

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Hypertension in obesity.

L Romayne Kurukulasuriya¹, Sameer Stas, Guido Lastra

¹Department of Internal Medicine, University of Missouri-Columbia School of Medicine, Columbia, MO 65212, USA. romayne1@health.missouri.edu

Endocrinology and Metabolism Clinics of North America

|September 9, 2008

Summary

Hypertension and obesity, key elements of cardiometabolic syndrome, are increasing globally. This review explores the complex relationship and mechanisms of obesity-related hypertension, highlighting the need for further research into effective treatments.

Related Experiment Videos

Last Updated: Jul 1, 2026

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Area of Science:

Cardiology
Metabolic Syndrome Research
Public Health

Background:

Hypertension and obesity are prevalent global health issues, significantly contributing to the cardiometabolic syndrome.
The worldwide increase in these conditions poses substantial health and economic challenges.
The intricate relationship between obesity and hypertension requires further elucidation.

Purpose of the Study:

To review current scientific knowledge on the mechanisms linking obesity and hypertension.
To provide an overview of the multifaceted etiology of obesity-related hypertension.
To emphasize the importance of understanding these mechanisms for future therapeutic strategies.

Main Methods:

Literature review of existing research on obesity-related hypertension.
Synthesis of current understanding regarding the complex relationship between the two conditions.
Analysis of the multifactorial causes contributing to obesity-induced hypertension.

Main Results:

Obesity is a significant driver of hypertension, contributing to the rising prevalence of cardiometabolic syndrome.
The mechanisms underlying obesity-related hypertension are complex and not fully understood.
Current knowledge highlights the multifaceted nature of this epidemic.

Conclusions:

Understanding the intricate mechanisms of obesity-related hypertension is crucial for public health.
Further research is needed to develop effective treatment strategies for this growing epidemic.
Addressing the rise in obesity and hypertension is essential for mitigating global health and economic consequences.